The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Seminars in Medicine of the Beth Israel Deaconess Medical Center
PreviousPrevious
Volume 332:934-940 April 6, 1995 Number 14
NextNext

Dementia Associated with the Acquired Immunodeficiency Syndrome
Stuart A. Lipton, M.D., Ph.D., and Howard E. Gendelman, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Approximately one third of adults and half of children with the acquired immunodeficiency syndrome (AIDS) eventually have neurologic complications, which are directly attributable to infection of the brain by the human immunodeficiency virus type 1 (HIV-1).1,2 Neurologic problems occur even in the absence of opportunistic infection or secondary cancer.3 Important clinical manifestations include impaired mental concentration, slowness of hand movements, and difficulty in walking. This malady has been called the AIDS dementia complex by Price and colleagues3; a more recent term is HIV-1–associated cognitive–motor complex.

Pathologically, the signs of HIV-1 infection in the central nervous system (or HIV encephalitis) . . . [Full Text of this Article]

Neuronal Injury Mediated by Brain Macrophages

Involvement of Various Types of Cell in HIV-Related Neuronal Injury

Nitric Oxide

HIV-1 Coat Protein gp120 and Neuronal Injury

NMDA Antagonists for the Prevention of AIDS Dementia

Discussion


Source Information

From the Laboratory of Cellular and Molecular Neuroscience, Department of Neurology, Children's Hospital (S.A.L.); the Departments of Neurology, Beth Israel Hospital, Brigham and Women's Hospital, and Massachusetts General Hospital (S.A.L.); and the Program in Neuroscience, Harvard Medical School (S.A.L.) — all in Boston; and the Laboratory of Viral Pathogenesis, Departments of Pathology and Microbiology and Medicine, and the Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha (h.E.G.).

Address reprint requests to Dr. Lipton at Children's Hospital–Harvard Medical School, 300 Longwood Ave., Enders Bldg., Suite 361, Boston, MA 02115.

References


Related Letters:

Nitric Oxide and AIDS Dementia
Fuchs D., Baier-Bitterlich G., Wachter H., Lipton S. A., Gendelman H. E.
Extract | Full Text  
N Engl J Med 1995; 333:521-522, Aug 24, 1995. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.